,FRANCE — French pharmaceutical firm Sanofi on Friday (March 12) announced the launch of human trials of its second Covid-19 vaccine, with its first still in the testing phase after having fallen behind in development.rrSanofi and US company Translate Bio are developing the vaccine based on messenger RNA technology.rrThe phase 1 and 2 trials aim to verify that the vaccine is not dangerous and to provide initial information on its effectiveness.rrPhase 3 would be carried out on many more patients to determine its effectiveness. rrThe first trials will include 415 people, with initial results expected in the third quarter.rrMessenger RNA technology is also used in the Pfizer-BioNTech and Moderna vaccines, already authorised in the European Union, the United States and elsewhere. rrIt is the second vaccine developed by Sanofi against the coronavirus. rrAn earlier candidate, developed with Britain's GSK, is recombinant protein-based, but its development is several months behind schedule and testing is only in phase 2, with hopes to launch it in late 2021.rrSanofi has also agreed to help produce Covid vaccines developed by Pfizer and Johnson & Johnson. AFPr
if you want to buy apple account, choose buyappleacc.com, buyappleacc.com is a best provider within bussiness for more than 3 years. choose us, you will never regret. we provied worldwide apple developer account for sale.